Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 60 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-04-20 Woiwode Thomas Director Other disposition −92,918 0
2018-04-20 Woiwode Thomas Director Other acquisition +2,323 7,282
2018-04-20 Bolzon Bradley J PhD Director Other disposition −497,053 2,238,979
2018-04-20 Bolzon Bradley J PhD Director Other disposition −2,947 13,277
2018-04-20 Bolzon Bradley J PhD Director Other acquisition +92,918 92,918
2018-04-20 Bolzon Bradley J PhD Director Other disposition −92,918 0
2018-04-20 Bolzon Bradley J PhD Director Other acquisition +16,262 43,986
2018-04-16 Kulkarni Samarth Chief Executive Officer Grant or award · Stock Option (Right to Buy) −75,000 150,000
2018-03-07 Ho Tony W See Remarks Grant or award · Stock Option (Right to Buy) +53,000 53,000
2018-03-07 Kulkarni Samarth Chief Executive Officer Grant or award · Stock Option (Right to Buy) +136,000 136,000
2018-03-07 KASINGER JAMES R. General Counsel and Secretary Grant or award · Stock Option (Right to Buy) +40,000 40,000
2018-03-07 TOMSICEK MICHAEL JOHN Chief Financial Officer Grant or award · Stock Option (Right to Buy) +25,000 25,000
2018-01-16 Dylan-Hyde Tyler Chief Legal Officer Sale −45,000 $28.00 $1.3M 25,204
2018-01-16 Dylan-Hyde Tyler Chief Legal Officer Option exercise +1,110 $12.57 $14K 26,314
2018-01-16 Dylan-Hyde Tyler Chief Legal Officer Sale −1,110 $28.24 $31K 25,204
2018-01-16 Dylan-Hyde Tyler Chief Legal Officer Option exercise +19,890 $12.57 $250K 45,094
2018-01-16 Dylan-Hyde Tyler Chief Legal Officer Sale −19,890 $28.10 $559K 25,204
2018-01-16 Dylan-Hyde Tyler Chief Legal Officer Option exercise · Stock Option (Right to Buy) −1,110 36,663
2018-01-16 Dylan-Hyde Tyler Chief Legal Officer Option exercise · Stock Option (Right to Buy) −19,890 5,237
2018-01-05 BAYER AKTIENGESELLSCHAFT 10% owner Purchase +527,472 $22.75 $12.0M 5,632,802

Page 55 of 62 · 1,221 trades